Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

52 results about "Oa osteoarthritis" patented technology

Sometimes called degenerative joint disease or “wear and tear” arthritis, osteoarthritis (OA) is the most common chronic condition of the joints. It occurs when the cartilage or cushion between joints breaks down leading to pain, stiffness and swelling. pain.

Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof

InactiveUS20100292156A1Surprising efficacyBiocideOrganic active ingredientsIntraarticular InjectionsDrug
Disclosed are pharmaceutical compositions containing, as the active ingredients, a mixture of a hyaluronic acid polymer with a bradykinin B2 receptor antagonist. Said compositions have proved especially effective in the treatment of degenerative joint diseases such as osteoarthritis using intra-articular injections.
Owner:IST LUSO FARMACO D ITALA SRL

Traditional Chinese medicine composition for treating knee osteoarthritis

ActiveCN111184792ADelay disease progressionEffective treatment of combined synovitisAntipyreticAnalgesicsCyathula officinalisWolfiporia extensa
The invention provides a traditional Chinese medicine composition for treating osteoarthritis and a preparation method thereof. The traditional Chinese medicine composition is prepared from from the following raw material medicines in parts by weight: 10-20 parts of poria cocos, 5-15 parts of cassia twigs, 2-8 parts of rhizoma atractylodis, 2-8 parts of cortex phellodendri, 2-8 parts of radix stephaniae tetrandrae, 2-8 parts of polyporus umbellatus, 2-8 parts of rhizoma drynariae, 5-15 parts of rhizoma corydalis and 3-9 parts of radix cyathulae. The composition disclosed by the invention has the functions of tonifying spleen, promoting diuresis, dispelling wind, clearing heat, dredging collaterals and relieving pain, and is clinically applicable to patients suffering from rheumatic fever arthralgia in the attack stage of knee osteoarthritis, wherein the patients have the symptoms of swelling, pain, unfavorable flexion and extension and even local pyrexia, redness and swelling of joints, fat and big tongue body with tooth prints, yellow and greasy tongue coating and few pulse strings. When the composition provided by the invention is used for intervening in a rabbit with knee osteoarthritis, results show that the composition can relieve symptoms like joint swelling and skin temperature rise of the rabbit with knee osteoarthritis, improve joint functions, reduce the contents of IL-1[beta], TNF[alpha], PGE2 and NO in joints, relieve synovitis and delay the progress of knee osteoarthritis. Clinical observation results show that the composition provided by the invention has theeffects of relieving swelling and pain and improving joint functions for patients with knee osteoarthritis.
Owner:陈卫衡 +1

Treatment model for osteoarthritis by human adipose-derived stem cells and treatment method thereof

The invention discloses a treatment model for osteoarthritis by human adipose-derived stem cells and a treatment method thereof. The treatment method of the model comprises the following steps: P1, preparing a stem cell injection; P2, establishing an osteoarthritis model; P3, performing model separation; P4, performing interventional therapy; P5, performing tissue observation; P6, performing result statistics; and P7, performing contrast. The invention provides the treatment model for osteoarthritis by human adipose-derived stem cells and the treatment method thereof, the tubular joint induction is carried out on an experimental white mouse, the joint tube disease position and deterioration degree can be effectively controlled, meanwhile, two different forms of local injection treatment and intravenous injection treatment are combined, the intervention result is compared and analyzed, the change process and the intervention direction can be easily controlled, meanwhile, the intervention result is archived and compared and analyzed, the optimal solution can be easily obtained, the stem cell effect and differentiation effect are improved, the treatment effect is improved, and control, use and popularization are facilitated.
Owner:YANTAI ZHIXING INTPROP CONSULTATION SERVICES CO LTD

Purpose of Chinese herba preparation in treating osteoarthritis

The invention relates to a purpose of a Chinese herba preparation in treating osteoarthritis in an external use paster. The Chinese herba preparation comprises, by weight, 10-20 parts of radix angelicae pubescentis, 10-20 parts of dandelion, 10-20 parts of erodium stephanianum willd, 10-20 parts of goldthread, 10-20 parts of cactuses, 10-20 parts of bark of Chinese redbud, 5-10 parts of centipeda minima, 5-10 parts of golden cypress, 5-10 parts of toad, 5-10 parts of rhizoma calami, 5-10 parts of the root bark of white mulberry, 5-10 parts of corydalis tuber, 10-15 parts of notopterygium roots, 10-15 parts of spina gleditsiae, 10-15 parts of aloes, 10-15 parts of fructus cnidii, 15-20 parts of ramulus mori, 15-20 parts of fructus evodiae, 15-20 parts of ligusticum wallichii, 15-20 parts of rattletop, 15-20 parts of radix aconiti preparata and 15-20 parts of liquorice. The compatibility of the osteoarthritis paster conforms to the traditional Chinese medicine assistant and guide principle, the components are scientific and reasonable, the drugs are in transdermal absorption, the drug efficacy can go straight to the affected part during treatment, the joint pressing pain and bump can be rapidly relieved, and the osteoarthritis paster has the advantages of being fast in effect taking, free of toxic and side effect, low in cost and the like; meanwhile, the relapse cannot happen after treatment, the satisfied short-term curative effect is achieved, and a good long-term curative effect is also achieved.
Owner:TAICANG SIRUI BIOLOGICAL SCI & TECH

Composition for relieving osteoarthritis pain and application thereof

The invention relates to a composition for relieving osteoarthritis pain and application thereof, and belongs to the technical field of traditional Chinese medicines. The composition for relieving the osteoarthritis pain comprises the following components in parts by weight: 25-85 parts of a procumbent pseudo-ginseng and chrysanthemum extract, 10-35 parts of a vinegar-processed curcuma zedoary extract and 5-25 parts of a fried szechwan chinaberry fruit extract. The composition for relieving the osteoarthritis pain contains the procumbent pseudo-ginseng and chrysanthemum extract, and has various pharmacological effects of resisting inflammation, resisting infection and the like; the curcuma zedoary extract has the effects of promoting qi circulation, breaking blood, removing food retention and relieving pain; the szechwan chinaberry fruit has the effects of soothing liver and relieving heat, promoting qi circulation and relieving pain and killing insects; and a large number of studies find that the procumbent pseudo-ginseng and chrysanthemum extract, the curcuma zedoary extract and the szechwan chinaberry fruit extract in the composition have a synergistic effect, and the composition has the remarkable effects of promoting qi to activate blood and activating meridians to stop pain on relieving slight or moderate pain of osteoarthritis and pain such as traumatic injuries, sprains, muscular pain and fractures.
Owner:完美(广东)日用品有限公司 +2

Composition, for osteoarthritis treatment, comprising hydrophilized sulfasalazine and hyaluronic acid and method for preparing same

The present invention relates to a composition for treating osteoarthritis and a method for preparing the same, and more specifically, relates to a composition comprising hydrophilized sulfasalazine as an active ingredient and hyaluronic acid so as to enable effective treatment of osteoarthritis such as degenerative osteoarthritis by preventing joint wear in addition to symptom relief through intraarticular or local administration, and a method for preparing the same. When such a composition for osteoarthritis treatment is prepared by the preparation method according to the present invention, the dissolved state is maintained beyond a neutralization step after dissolution, preventing precipitation of sulfalazine by salting out occurring after neutralization, and thus a composition comprising high concentration of sulfasalazine can be prepared, and the composition prepared accordingly is highly effective in treating osteoarthritis, particularly degenerative osteoarthritis, through the intraarticular or local administration, since it comprises high concentration of sulfasalazine which had to be formulated at low concentration by conventional method due to poor solubility.
Owner:BMI KOREA CO LTD

Anti-inflammatory and analgesic traditional Chinese medicine composition and its preparation method and application

The invention discloses an anti-inflammatory and analgesic traditional Chinese medicine composition and its preparation method and application. The anti-inflammatory and analgesic traditional Chinese medicine composition is made of active components alone or mixed with active components and common auxiliary materials for pharmaceutical preparations to form an external dosage form. The active ingredient is prepared from mugwort leaves, impatiens, prickly ash and black ants according to a certain weight percentage. The anti-inflammatory and analgesic traditional Chinese medicine composition of the present invention adopts pure natural traditional Chinese medicine as a raw material, has no side effects, is safe and reliable, has wide distribution of medicinal materials, simple preparation process, low price of extraction solvent, stable and controllable quality, and is easy to scale up. In addition, the traditional Chinese medicine composition provided by the present invention, after combining the four traditional Chinese medicines of Artemisia argyi, Impatiens, Zanthoxylum bungeanum and black ant, has played a synergistic effect, has obvious analgesic and anti-inflammatory effects on osteoarthritis, and can significantly improve osteoarthritis. Joint swelling and pain, poor flexion and extension and other lesions provide new options for clinical medication.
Owner:CHINA ACAD OF SCI NORTHWEST HIGHLAND BIOLOGY INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products